Beer and prevention: new study tests alcohol counseling to boost HIV drug adherence
NCT ID NCT06036238
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a brief alcohol counseling program helps high-risk adults who drink heavily stay on HIV prevention medication (PrEP or PEP). Researchers will enroll 400 people at drinking venues in Kenya and Uganda, giving half the counseling and half standard care. They will track how long participants stick with their prevention meds over 24 and 48 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Healthy Living Intervention (HLI) - a brief alcohol counseling program
What this could lead to
If successful, this could show that adding alcohol counseling helps people with heavy drinking stay on HIV prevention medication, reducing new infections.
What could go wrong
This is a behavioral study with 400 participants, so results may not apply broadly. Adherence depends on many factors, and the counseling may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Infectious Diseases Research Collaboration (IDRC)
RECRUITINGMbarara, Uganda
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kenya Medical Research Institute (KEMRI)
RECRUITINGMbita, Kenya
Contact
Contact Email: •••••@•••••